{"DataElement":{"publicId":"5505876","version":"1","preferredName":"Agent Asparaginase Administered Biomarker International Unit per Milliliter Value","preferredDefinition":"The numeric IU/mL value that represents the asparaginase level.","longName":"ASPGN_ADMIN_IU_ML_LEVEL","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"5505435","version":"1","preferredName":"Agent Asparaginase Administered","preferredDefinition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect._An enzyme isolated from the bacterium Escherichia coli or the bacterium Erwinia carotovora with antileukemic activity. Asparaginase hydrolyzes L-asparagine to L-aspartic acid and ammonia in leukemic cells, resulting in the depletion of asparagine, inhibition of protein synthesis, cell cycle arrest in the G1 phase, and apoptosis in susceptible leukemic cell populations. Asparagine is critical to protein synthesis in leukemic cells; some leukemic cells cannot synthesize this amino acid de novo due to the absent or deficient expression of the enzyme asparagine synthase. The E. carotovora-derived form of asparaginase is typically reserved for cases of asparaginase hypersensitivity._The act of having given something (e.g., a medication or test).","longName":"2223333v1.0:5505433v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2223333","version":"1","preferredName":"Agent","preferredDefinition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI)","longName":"C1708","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F62B10F2-76A7-2830-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7530376","version":"1","preferredName":"Asparaginase Administered","preferredDefinition":"An enzyme isolated from the bacterium Escherichia coli or the bacterium Erwinia carotovora with antileukemic activity. Asparaginase hydrolyzes L-asparagine to L-aspartic acid and ammonia in leukemic cells, resulting in the depletion of asparagine, inhibition of protein synthesis, cell cycle arrest in the G1 phase, and apoptosis in susceptible leukemic cell populations. Asparagine is critical to protein synthesis in leukemic cells; some leukemic cells cannot synthesize this amino acid de novo due to the absent or deficient expression of the enzyme asparagine synthase. The E. carotovora-derived form of asparaginase is typically reserved for cases of asparaginase hypersensitivity.:The act of having given something (e.g., a medication or test).","longName":"C286:C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Asparaginase","conceptCode":"C286","definition":"An enzyme isolated from the bacterium Escherichia coli or the bacterium Erwinia carotovora with antileukemic activity. Asparaginase hydrolyzes L-asparagine to L-aspartic acid and ammonia in leukemic cells, resulting in the depletion of asparagine, inhibition of protein synthesis, cell cycle arrest in the G1 phase, and apoptosis in susceptible leukemic cell populations. Asparagine is critical to protein synthesis in leukemic cells; some leukemic cells cannot synthesize this amino acid de novo due to the absent or deficient expression of the enzyme asparagine synthase. The E. carotovora-derived form of asparaginase is typically reserved for cases of asparaginase hypersensitivity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B632AB3E-B7E6-0B8C-E053-4EBD850A6E95","latestVersionIndicator":"Yes","beginDate":"2020-12-11","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-12-11","modifiedBy":"ONEDATA","dateModified":"2020-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435024","version":"1","preferredName":"Drug or Chemical","preferredDefinition":"A category of organic or inorganic substances, elements, and isotopes used in research or for the prevention, diagnosis, and/or treatment of disease states. Includes biologically active substances that are either synthetically manufactured or endogenous substances extracted and processed to be reintroduced into an organism. Chemicals and drugs also include hazardous substances, and naturally occurring or synthetically produced substances required to maintain life.","longName":"C1908","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07431EBC-FB04-25D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E22C39F-86C6-7F2E-E053-F662850A5DDD","latestVersionIndicator":"Yes","beginDate":"2016-10-05","endDate":null,"createdBy":"DAVISJ","dateCreated":"2016-10-05","modifiedBy":"SETRAKIN","dateModified":"2020-12-11","changeDescription":"Workflow and Registration Status Changed per Brenda Duggan; 05.16.18; Made compliant and workflow revised 12.11.20 NS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5505465","version":"1","preferredName":"Biomarker International Unit per Milliliter Value","preferredDefinition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention._A unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one milliliter of system volume._A numerical quantity measured or assigned or computed.","longName":"5505465v1.0","context":"COG","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"IU/mL","minLength":null,"maxLength":"12","minValue":null,"maxValue":null,"decimalPlace":"2","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008558","version":"1","preferredName":"Units of Measure","preferredDefinition":"the units of measure for assessment results and dosing.","longName":"UOM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2DECB93-42CA-248A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-28","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-28","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"14622975","version":"1","preferredName":"Biomarker International Unit per Milliliter Value","preferredDefinition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention._A unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one milliliter of system volume._A numerical quantity measured or assigned or computed.","longName":"14622975v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biomarker","conceptCode":"C16342","definition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"International Unit per Milliliter","conceptCode":"C67377","definition":"A unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one milliliter of system volume.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B2A3A85-E38D-2161-E063-731AD00A83A4","latestVersionIndicator":"Yes","beginDate":"2023-11-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-27","modifiedBy":"KUMMEROA","dateModified":"2023-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"3E2320F7-7145-4175-E053-F662850AC5E7","latestVersionIndicator":"Yes","beginDate":"2016-10-05","endDate":null,"createdBy":"DAVISJ","dateCreated":"2016-10-05","modifiedBy":"KUMMEROA","dateModified":"2023-11-27","changeDescription":"Workflow and Registration Status Changed per Brenda Duggan; 05.16.18","administrativeNotes":"2023.11.27 Took out of retirement for use. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Asparaginase level (IU/mL):","type":"Preferred Question Text","description":"Asparaginase level (IU/mL):","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Asparaginase level (IU per mL):","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"3E2490D5-76F8-2A1B-E053-F662850AF391","latestVersionIndicator":"Yes","beginDate":"2016-10-05","endDate":null,"createdBy":"DAVISJ","dateCreated":"2016-10-05","modifiedBy":"KUMMEROA","dateModified":"2023-11-27","changeDescription":"Workflow and Registration Status changes per Brenda Duggan; 05.16.18","administrativeNotes":"2023.11.27 Took out of retirement for use.  ak","unresolvedIssues":null,"deletedIndicator":"No"}}